Radhakrishnan Srikanth's Form 4 filing
Pulmonx Corp (LUNG) · filed Jun 3, 2026
- Accession no.
- 0002098678-26-000002
- Filed
- Jun 3, 2026
- Trade date
- Jun 1, 2026
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 4 non-derivative transactions and 0 derivative transactions. Open-market sales total $22.3K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Radhakrishnan SrikanthCIK 0002098678 | Officer (Chief Science &Techn. Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jun 1, 2026 | Common Stock | SSaleDisposed | −2,691 | $1.54 | −$4,144.14 | 343,045 | Direct | |
| Jun 1, 2026 | Common Stock | SSaleDisposed | −2,153 | $1.54 | −$3,315.62 | 340,892 | Direct | |
| Jun 1, 2026 | Common Stock | SSaleDisposed | −3,684 | $1.54 | −$5,673.36 | 337,208 | Direct | |
| Jun 1, 2026 | Common Stock | SSaleDisposed | −5,969 | $1.54 | −$9,192.26 | 331,239 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.